MOESM1 of Long noncoding RNA dysregulation in ischemic heart failure

Additional file 1: Table S1. Disease association of the lncRNAs of the SBI "Disease-related human lncRNA profiler" plate. Table S2: Sequences and gene alignment of the primers designed for validation. Table S3: Single nucleotide polymorphism (SNPs) analysis of CDKN2-AS1. Table S4: Differentially expressed protein coding genes neighboring the HF modulated lncRNAs. Table S5: Non end-stage HF LncRNAs signature in end-stage HF patients. Table S6: HF-modulated mRNAs correlating with HF-modulated lncRNAs. Table S7: Pathway enrichment analysis of HF-modulated mRNAs correlating with HF-modulated lncRNAs. Table S8: Significantly enriched pathways in common between LV and PBMC datasets in HF patients.

附加文件1：表S1：SBI“疾病相关人类长链非编码RNA（long non-coding RNA, lncRNA）分析板”所包含长链非编码RNA的疾病关联分析。表S2：用于验证的引物序列及基因比对结果。表S3：CDKN2-AS1的单核苷酸多态性（Single Nucleotide Polymorphism, SNPs）分析。表S4：心力衰竭（Heart Failure, HF）调控型长链非编码RNA邻近的差异表达蛋白编码基因。表S5：终末期心力衰竭患者体内的非终末期心力衰竭长链非编码RNA特征谱。表S6：与心力衰竭调控型长链非编码RNA相关的心力衰竭调控型信使RNA（mRNA）。表S7：与心力衰竭调控型长链非编码RNA相关的心力衰竭调控型信使RNA的通路富集分析。表S8：心力衰竭患者左心室（Left Ventricle, LV）与外周血单个核细胞（Peripheral Blood Mononuclear Cell, PBMC）数据集中共有的显著富集通路。